Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
about
Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trialThe fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the fieldAzithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment roundsA rationale for continuing mass antibiotic distributions for trachomaRole of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous diseaseReduction and return of infectious trachoma in severely affected communities in Ethiopia.Mass antibiotic treatment alone does not eliminate ocular chlamydial infection.When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countriesImportance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distributionClinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachomaDesign and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BCInhibitory effects of 405 nm irradiation on Chlamydia trachomatis growth and characterization of the ensuing inflammatory response in HeLa cellsActive trachoma two years after three rounds of azithromycin mass treatment in Cheha District Gurage Zone, Southern EthiopiaOptimal seasonal timing of oral azithromycin for malaria.Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma.Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.Adverse events after mass azithromycin treatments for trachoma in EthiopiaHow reliable are tests for trachoma?--a latent class approach.What's new in azithromyin?The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.Association of community antibiotic consumption with clinically active trachoma in rural Ethiopia.Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial?Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?'If an Eye Is Washed Properly, It Means It Would See Clearly': A Mixed Methods Study of Face Washing Knowledge, Attitudes, and Behaviors in Rural Ethiopia.Epidemiology and control of trachoma: systematic review.The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing.Prospects for the control of neglected tropical diseases by mass drug administration.Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.Travel and implications for the elimination of trachoma in ethiopia.Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania.Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.Topical azithromycin: new evidence?Trachoma, antibiotics and randomised controlled trials.A framework for public health action: the health impact pyramid.Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination.Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional studyManaging the emergence of pathogen resistance via spatially targeted antimicrobial use
P2860
Q28476520-95EEEBDA-A49A-496B-A95B-F6014266AD2FQ28478903-FF33005B-AD91-4966-A83D-83ED55E9C028Q28481585-EFBB0F94-9A61-419E-9721-F28175E6D1DCQ33293477-2C0580E5-A04D-42A2-BB3B-5CCBBC6AEFADQ33352045-195A18EC-C16B-4B85-9E4B-5AE24220DA8EQ33405255-5A7FE0B1-1E86-4F91-B3C4-65877B800466Q33424456-7D32A919-91FE-4534-9F70-9C443226F75DQ33468389-B17D6ED5-3F9D-40BB-BC2F-D8DBBFAF34D9Q33496749-3BEA2780-9745-4B3C-9DD6-F4F94CCE1852Q33693683-F706E9D0-E14B-4DF8-AB50-F187393CA7EFQ33806236-3E5665C4-0F5C-4F0D-9EA9-844DD45FCF68Q34123778-B8E26B5B-F897-4EF6-BAE7-CD47534CF53BQ34380815-1E3C36F7-51C5-4038-946C-7A92A4281126Q34449132-4477CD06-31A4-438F-AE71-734454A798BDQ34496220-34730678-16E5-4BAA-AA6C-A491E56F4FD8Q34735317-75B7F193-A541-452A-9BD1-F7B81C5E80A0Q34855220-C6B01208-FEF1-4436-9694-C4FD23D8FDE9Q35116687-C15F0D41-B8FC-4094-B7F8-B68783E28BD9Q35131411-82455177-E1C3-4869-8185-64C491D3A28EQ35221151-B54FB0E2-AAB6-44F2-9B12-AD33AB798A35Q35230503-91AF1C54-0627-4468-A171-42A2A490E29FQ35571651-2D764226-BCE3-4326-80C1-C5D45479C12FQ35667990-84686201-BE59-41CD-AD42-8BA1A2B4654DQ35762637-F073B653-67E2-4165-B9C4-76576A2006F8Q35763113-18DE1179-8A21-41D1-954E-E9EDD85F3E89Q35798895-845E8EDA-5EE8-47FB-86BA-49CE7B42ADE4Q36176201-E7C2A128-8B88-49D0-9A0B-070255B9F1F1Q37165258-A593CCA7-C169-4D94-84BF-CD542D48C792Q37179222-72D2D9E4-C141-4F29-A825-AEAF99A1A5ABQ37557676-96D145EC-7E44-4D9F-A54A-DE901F27E1E2Q37849443-B87468D2-A281-4BAA-9531-20FA10475978Q37853415-5F0DC83E-37DB-4C63-90DE-D78CD6F40B7BQ37855030-A898102C-22BE-4D44-854F-7B72DB8CCBF7Q40046816-4156FC57-0894-4733-858E-C0835767C5F5Q42410173-3FF64ECD-484D-4FBB-BF99-ED1A6C71FA7FQ42840992-A58938A9-42BB-4CC9-B23D-C735FFF2E1A4Q55052605-860887A3-9FB6-4F25-A239-B24746157DE0Q55229858-51FDF5AF-DF54-498A-B9E3-00CB86544217Q58798816-0B6E6908-E44C-42F8-8932-4D4D79C401B8Q59136516-72C7F41D-D12C-4F5C-91CC-B590D5F21EBE
P2860
Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Feasibility of eliminating ocu ...... at mass antibiotic treatments.
@en
Feasibility of eliminating ocu ...... at mass antibiotic treatments.
@nl
type
label
Feasibility of eliminating ocu ...... at mass antibiotic treatments.
@en
Feasibility of eliminating ocu ...... at mass antibiotic treatments.
@nl
prefLabel
Feasibility of eliminating ocu ...... at mass antibiotic treatments.
@en
Feasibility of eliminating ocu ...... at mass antibiotic treatments.
@nl
P2093
P50
P356
P1476
Feasibility of eliminating ocu ...... eat mass antibiotic treatments
@en
P2093
Cathy Donnellan
David Chung Lee
Elizabeth H Yi
John P Whitcher
Michael Saidel
Muluken Melese
Thomas M Lietman
Vicky Cevallos
P304
P356
10.1001/JAMA.292.6.721
P407
P577
2004-08-01T00:00:00Z